Advertisement
Research Article| Volume 23, ISSUE 3, P291-301, April 2023

Download started.

Ok

Circ_0108942 Regulates the Progression of Breast Cancer by Regulating the MiR-1178-3p/TMED3 Axis

  • Author Footnotes
    # Chuansheng Yang and Meijiao Wang contribute to this work equally as co-first authors.
    Chuansheng Yang
    Footnotes
    # Chuansheng Yang and Meijiao Wang contribute to this work equally as co-first authors.
    Affiliations
    Department of Head-Neck and Breast Surgery, Yuebei People's Hospital of Shantou University, Shaoguan, Guangdong, China
    Search for articles by this author
  • Author Footnotes
    # Chuansheng Yang and Meijiao Wang contribute to this work equally as co-first authors.
    Meijiao Wang
    Footnotes
    # Chuansheng Yang and Meijiao Wang contribute to this work equally as co-first authors.
    Affiliations
    Operation room, Yuebei People's Hospital of Shantou University, Shaoguan, Guangdong, China
    Search for articles by this author
  • Renfeng Huang
    Affiliations
    Department of Head-Neck and Breast Surgery, Yuebei People's Hospital of Shantou University, Shaoguan, Guangdong, China
    Search for articles by this author
  • Linyang Ou
    Affiliations
    Department of Head-Neck and Breast Surgery, Yuebei People's Hospital of Shantou University, Shaoguan, Guangdong, China
    Search for articles by this author
  • Min Li
    Affiliations
    Department of Head-Neck and Breast Surgery, Yuebei People's Hospital of Shantou University, Shaoguan, Guangdong, China
    Search for articles by this author
  • Wanming Wu
    Affiliations
    Department of Head-Neck and Breast Surgery, Yuebei People's Hospital of Shantou University, Shaoguan, Guangdong, China
    Search for articles by this author
  • Ruiwen Lei
    Correspondence
    Address for correspondence: Ruiwen Lei, MM, Department of Head-Neck and Breast Surgery, Yuebei People's Hospital of Shantou University, 133 Huimin South Road, Wujiang District, Shaoguan 512026, Guangdong, China
    Affiliations
    Department of Head-Neck and Breast Surgery, Yuebei People's Hospital of Shantou University, Shaoguan, Guangdong, China
    Search for articles by this author
  • Author Footnotes
    # Chuansheng Yang and Meijiao Wang contribute to this work equally as co-first authors.
Published:December 22, 2022DOI:https://doi.org/10.1016/j.clbc.2022.12.014

      Highlights

      • The expression of circ_0108942 was upregulated in BC.
      • Circ_0108942 knockdown inhibited cell proliferation, migration, invasion, and angiopoiesis, and promoted apoptosis in BC cells.
      • Circ_0108942 promoted the progression of BC by sponging miR-1178-3p.
      • MiR-1178-3p inhibited BC progression by targeting TMED3.

      Abstract

      Background

      Breast cancer (BC) has posed a fatal threat to women's lives and the search for new methods of diagnosis and treatment is an important way to break the bottleneck of high mortality in BC. Circular RNAs (circRNAs) have been confirmed to be aberrantly expressed in several types of cancers, and this study is intended to elucidate the role and mechanism of circ_0108942 in BC.

      Materials and Methods

      The levels of circ_0108942, microRNA-1178-3p (miR-1178-3p), and transmembrane p24 trafficking protein 3 (TMED3) were measured using real-time quantitative polymerase chain reaction (RT-qPCR) or western blot. Meanwhile, the cell proliferation, migration, invasion, angiopoiesis, and apoptosis were analyzed using 5-ethynyl-2′-deoxyuridine (EdU), transwell, tubule formation, and flow cytometry assays. Protein levels were determined by western blot. In addition, we used dual-luciferase reporter and RNA pull-down assays to identify the interplay between miR-1178-3p and circ_0108942 or TMED3. Lastly, the impact of circ_0108942 on the growth of BC tumors in vivo was analyzed by xenograft models.

      Results

      Circ_0108942 and TMED3 were notably upregulated in BC, and the miR-1178-3p was downregulated. Functionally, silencing circ_0108942 suppressed cell proliferation, migration, invasion and promoted apoptosis in BC cells. In mechanism, circ_0108942 regulated TMED3 expression by sponging miR-1178-3p. Meanwhile, circ_0108942 knockdown also greatly constrained tumor growth in vivo.

      Conclusion

      Circ_0108942 boosted BC progression by regulating miR-1178-3p and thus upregulating TMED3.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Breast Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Liang Y
        • Zhang H
        • Song X
        • Yang Q
        Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets.
        Semin Cancer Biol. 2020; 60: 14-27
        • Wörmann B
        Breast cancer: basics, screening, diagnostics and treatment.
        Med Monatsschr Pharm. 2017; 40: 55-64
        • Pearce L
        Breast cancer.
        Nurs Stand. 2016; 30: 15
        • Maughan KL
        • Lutterbie MA
        • Ham PS
        Treatment of breast cancer.
        Am Fam Physician. 2010; 81: 1339-1346
        • Fahad Ullah M
        Breast cancer: current perspectives on the disease status.
        Adv Exp Med Biol. 2019; 1152: 51-64
        • Zheng S
        • Zou Y
        • Xie X
        • et al.
        Development and validation of a stromal immune phenotype classifier for predicting immune activity and prognosis in triple-negative breast cancer.
        Int J Cancer. 2020; 147: 542-553
        • MB A
        • VS R
        • ME J
        • AO A
        Breast cancer biomarkers: risk assessment, diagnosis, prognosis, prediction of treatment efficacy and toxicity, and recurrence.
        Curr Pharm Des. 2014; 20: 4879-4898
        • Yang L
        • Li N
        • Xue Z
        • et al.
        Synergistic therapeutic effect of combined PDGFR and SGK1 inhibition in metastasis-initiating cells of breast cancer.
        Cell Death Differ. 2020; 27: 2066-2080
      1. Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, The biogenesis, biology and characterization of circular RNAs. 2019; 20:675-691.

        • Memczak S
        • Jens M
        • Elefsinioti A
        • et al.
        Circular RNAs are a large class of animal RNAs with regulatory potency.
        Nature. 2013; 495: 333-338
        • Rybak-Wolf A
        • Stottmeister C
        • Glažar P
        • et al.
        Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed.
        Molecular cell. 2015; 58: 870-885
        • Altesha MA
        • Ni T
        • Khan A
        • Liu K
        • Zheng X
        Circular RNA in cardiovascular disease.
        J Cell Physiol. 2019; 234: 5588-5600
        • Kristensen LS
        • Andersen MS
        • Stagsted LVW
        • Ebbesen KK
        • Hansen TB
        • Kjems J
        The biogenesis, biology and characterization of circular RNAs.
        Nat Rev Genet. 2019; 20: 675-691
        • Wu Y
        • Lu X
        • Shen B
        • Zeng Y
        The therapeutic potential and role of miRNA, lncRNA, and circRNA in osteoarthritis.
        Curr Gene Ther. 2019; 19: 255-263
        • Yang Y
        • Yujiao W
        • Fang W
        • et al.
        The roles of miRNA, lncRNA and circRNA in the development of osteoporosis.
        Biol Res. 2020; 53: 40
        • Liu Y
        • Yang Y
        • Wang Z
        • et al.
        Insights into the regulatory role of circRNA in angiogenesis and clinical implications.
        Atherosclerosis. 2020; 298: 14-26
        • Deepthi K
        • Jereesh AS
        An ensemble approach for CircRNA-disease association prediction based on autoencoder and deep neural network.
        Gene. 2020; 762145040
        • Li R
        • Jiang J
        • Shi H
        • Qian H
        • Zhang X
        • Xu W
        CircRNA: a rising star in gastric cancer.
        Cell Mol Life Sci. 2020; 77: 1661-1680
        • Jemal A
        • Bray F
        • Center MM
        • Ferlay J
        • Ward E
        • Forman D
        Global cancer statistics.
        CA Cancer J Clin. 2011; 61: 69-90
        • Sève P
        • Reiman T
        • Dumontet C
        The role of betaIII tubulin in predicting chemoresistance in non-small cell lung cancer.
        Lung Cancer. 2010; 67: 136-143
        • Wang X
        • Chen T
        • Li C
        • et al.
        CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR.
        J Hematol Oncol. 2022; 15: 122
        • Zou Y
        • Zheng S
        • Xiao W
        • et al.
        circRAD18 sponges miR-208a/3164 to promote triple-negative breast cancer progression through regulating IGF1 and FGF2 expression.
        Carcinogenesis. 2019; 40: 1469-1479
        • Yin WB
        • Yan MG
        • Fang X
        • Guo JJ
        • Xiong W
        • Zhang RP
        Circulating circular RNA hsa_circ_0001785 acts as a diagnostic biomarker for breast cancer detection.
        Clin Chim Acta. 2018; 487: 363-368
        • Ma Y
        • Niu X
        • Yan S
        • Liu Y
        • Dong R
        • Li Y
        Circular RNA profiling facilitates the diagnosis and prognostic monitoring of breast cancer: A pair-wise meta-analysis.
        J Clin Lab Anal. 2021; 35: e23575
        • Lu TX
        • Rothenberg ME
        MicroRNA.
        J Allergy Clin Immunol. 2018; 141: 1202-1207
        • Wojciechowska A
        • Braniewska A
        • Kozar-Kamińska K
        MicroRNA in cardiovascular biology and disease.
        Adv Clin Exp Med. 2017; 26: 865-874
        • Rupaimoole R
        • Slack FJ
        MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.
        Nat Rev Drug Discov. 2017; 16: 203-222
        • Zhao C
        • Zhang J
        • Zhang S
        • et al.
        Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma.
        Oncol Rep. 2013; 30: 276-284
        • Liu H
        • Bi J
        • Dong W
        • et al.
        Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis.
        Mol Cancer. 2018; 17: 161
        • Wang LQ
        • Deng AC
        • Zhao L
        • Li Q
        • Wang M
        • Zhang Y
        MiR-1178-3p promotes the proliferation, migration and invasion of nasopharyngeal carcinoma Sune-1 cells by targeting STK4.
        J Biol Regul Homeost Agents. 2019; 33: 321-330
        • Strating JR
        • Hafmans TG
        • Martens GJ
        Functional diversity among p24 subfamily members.
        Biol Cell. 2009; 101: 207-219
        • Port F
        • Hausmann G
        • Basler K
        A genome-wide RNA interference screen uncovers two p24 proteins as regulators of Wingless secretion.
        EMBO Rep. 2011; 12: 1144-1152
        • Ha M
        • Moon H
        • Choi D
        • et al.
        Prognostic role of TMED3 in clear cell renal cell carcinoma: a retrospective multi-cohort analysis.
        Front Genet. 2019; 10: 355
        • Yang J
        • Huang H
        • Xiao D
        • Duan Y
        • Zheng Y
        • Chen Z
        Knockdown of TMED3 inhibits cell viability and migration and increases apoptosis in human chordoma cells.
        Int J Oncol. 2021; 58: 15
        • Zhang X
        • Luo Y
        • Li Q
        TMED3 promotes proliferation and migration in breast cancer cells by activating wnt/beta-catenin signaling.
        Onco Targets Ther. 2020; 13: 5819-5830
        • Pei J
        • Zhang S
        • Yang X
        • et al.
        Long non-coding RNA RP11-283G6.5 confines breast cancer development through modulating miR-188-3p/TMED3/Wnt/beta-catenin signalling.
        RNA Biol. 2021; 18: 287-302
        • Tu FL
        • Guo XQ
        • Wu HX
        • et al.
        Circ-0001313/miRNA-510-5p/AKT2 axis promotes the development and progression of colon cancer.
        Am J Transl Res. 2020; 12: 281-291
      2. Nebenfuehr S, Kollmann K, Sexl V, The role of CDK6 in cancer. 2020; 147:2988-2995.

        • Zhao G
        • Zhu Y
        • Eno CO
        • et al.
        Activation of the proapoptotic Bcl-2 protein Bax by a small molecule induces tumor cell apoptosis.
        Mol Cell Biol. 2014; 34: 1198-1207
        • Sun X
        • Kaufman PD
        Ki-67: more than a proliferation marker.
        Chromosoma. 2018; 127: 175-186
        • Yeo SK
        • Guan JL
        Breast cancer: multiple subtypes within a tumor?.
        Trends Cancer. 2017; 3: 753-760
        • Tray N
        • Taff J
        • Adams S
        Therapeutic landscape of metaplastic breast cancer.
        Cancer Treat Rev. 2019; 79101888
        • Meng S
        • Zhou H
        • Feng Z
        • et al.
        CircRNA: functions and properties of a novel potential biomarker for cancer.
        Mol Cancer. 2017; 16: 94
        • Lei B
        • Tian Z
        • Fan W
        • Ni B
        Circular RNA: a novel biomarker and therapeutic target for human cancers.
        Int J Med Sci. 2019; 16: 292-301
        • Chen S
        • Li T
        • Zhao Q
        • Xiao B
        • Guo J
        Using circular RNA hsa_circ_0000190 as a new biomarker in the diagnosis of gastric cancer.
        Clin Chim Acta. 2017; 466: 167-171
        • Shang X
        • Li G
        • Liu H
        • et al.
        comprehensive circular RNA profiling reveals that hsa_circ_0005075, a new circular RNA biomarker, is involved in hepatocellular crcinoma development.
        Medicine (Baltimore). 2016; 95: e3811
        • Sang Y
        • Chen B
        • Song X
        • et al.
        circRNA_0025202 regulates tamoxifen sensitivity and tumor progression via regulating the miR-182-5p/FOXO3a axis in breast cancer.
        Mol Ther. 2019; 27: 1638-1652
        • Fang C
        • Li JJ
        • Deng T
        • Li BH
        • Geng PL
        • Zeng XT
        Actinin-4 as a diagnostic biomarker in serum of breast cancer patients.
        Med Sci Monit. 2019; 25: 3298-3302
        • Mitra A
        • Pfeifer K
        • Park K-S
        Circular RNAs and competing endogenous RNA (ceRNA) networks.
        Transl Cancer Res. 2018; 7: S624-S628
        • Chen Q
        • Liu T
        • Bao Y
        • et al.
        CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway.
        Cancer Lett. 2020; 469: 68-77
        • Zheng H
        • Yang Y
        • Han J
        • et al.
        TMED3 promotes hepatocellular carcinoma progression via IL-11/STAT3 signaling.
        Sci Rep. 2016; 6: 37070
        • Mishra S
        • Bernal C
        • Silvano M
        • Anand S
        • Ruiz IAA
        The protein secretion modulator TMED9 drives CNIH4/TGFα/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases.
        Cell Death Dis. 2019; 38: 5817-5837
        • Xie A
        • Xu X
        TMED3 promotes the progression and development of lung squamous cell carcinoma by regulating EZR.
        Cancer Cell Int. 2021; 12: 804
      3. Xu W, Li Y, Ye X, et al., TMED3/RPS15A axis promotes the development and progression of osteosarcoma. 2021; 21:630.

        • Peng C
        • Huang K
        • Liu G
        • Li Y
        • Yu C
        MiR-876-3p regulates cisplatin resistance and stem cell-like properties of gastric cancer cells by targeting TMED3.
        J Gastroenterol Hepatol. 2019; 34: 1711-1719
        • Vainio P
        • Mpindi JP
        • Kohonen P
        • et al.
        High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer.
        PLoS One. 2012; 7: e39801
        • Pei J
        • Zhang J
        • Yang X
        • et al.
        TMED3 promotes cell proliferation and motility in breast cancer and is negatively modulated by miR-188-3p.
        Cancer Cell Int. 2019; 19: 75